Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 19, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 23, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001757216-26-000002
Filed / recorded
Feb 23, 2026, 10:31 PM UTC
Added to OQRO
Oct 2, 2026, 12:29 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
ZIMMER BIOMET HOLDINGS, INC.
Issuer CIK
1136869
Ticker
ZBH
Reporting person
Ivan Tornos
Relationship
Director, Officer
Officer title
Chairman, President and CEO
Security
Restricted Stock Units
Table
Derivative (Table II)
Transaction date
Feb 19, 2026
Transaction code
A
Shares / units
24,436
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
24,436
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each RSU represents a contingent right to receive one share of Company common stock.
On March 6, 2023, and on September 1, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned for both such grants to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 12,184 RSUs for March and 12,252 RSUs for September, totaling 24,436 RSUs, which will vest on March 6, 2026.